Kilbac 750
Form: Injection
Strength: 750mg/vial
Generic Name: Cefuroxime
Company: Incepta Pharmaceuticals Ltd.
MRP:৳ 125.0 (Injection)
Is Antibiotic: Yes
Indications
Kilbac 750 is used to treat infections caused by bacteria that are sensitive to Kilbac 750. This includes conditions like:
- Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
- Acute Bacterial Otitis Media caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis (beta-lactamase producing strains), or Streptococcus pyogenes.
Pharmacology
Kilbac 750 contains Cefuroxime, a second-generation antibiotic that kills bacteria by preventing them from making their cell walls. Kilbac 750 works against a wide range of Gram-positive and Gram-negative bacteria, including those that produce beta-lactamase.
Kilbac 750 also contains Clavulanic acid, which blocks beta-lactamase enzymes. This helps protect Cefuroxime from being broken down, making Kilbac 750 more effective in treating infections caused by bacteria resistant to some antibiotics.
Dosage & Administration
Adolescents and adults (13 years and older):
- Pharyngitis/tonsillitis: 250 mg twice a day for 5-10 days
- Acute bacterial maxillary sinusitis: 250 mg twice a day for 10 days
- Acute bacterial exacerbation of chronic bronchitis: 250-500 mg twice a day for 10 days
- Secondary bacterial infections of acute bronchitis: 250-500 mg twice a day for 5-10 days
- Uncomplicated skin infections: 250-500 mg twice a day for 10 days
- Uncomplicated urinary tract infections: 250 mg twice a day for 7-10 days
- Uncomplicated Gonorrhoea: 1000 mg twice a day, single dose
- Community acquired pneumonia: 250-500 mg twice a day for 5-10 days
- MDR Typhoid Fever: 500 mg twice a day for 10-14 days
- Early Lyme disease: 500 mg twice a day for 20 days
Pediatric patients (3 months to 12 years):
- Pharyngitis/Tonsillitis: 20 mg/kg/day twice a day for 5-10 days
- Acute otitis media: 30 mg/kg/day twice a day for 10 days
- Acute bacterial maxillary sinusitis: 30 mg/kg/day twice a day for 10 days
- Impetigo: 30 mg/kg/day twice a day for 10 days
Kilbac 750 can be taken with or without food.
Interaction
If taken with probenecid, Kilbac 750 increases the amount of the medicine in your body. Medicines that reduce stomach acidity may make Kilbac 750 less effective by reducing its absorption.
Contraindications
Kilbac 750 should not be taken by people who are allergic to cephalosporins or have Pseudomembranous Colitis.
Side Effects
Generally, Kilbac 750 is well tolerated. Some common side effects may include nausea, vomiting, diarrhea, and stomach pain. Prolonged use may cause the growth of resistant microorganisms. In rare cases (<0.2%), Kilbac 750 may cause kidney problems, severe allergic reactions, swelling, rashes, or other serious effects.
Pregnancy & Lactation
Kilbac 750 should be avoided during the first trimester if possible. However, Kilbac 750 can be safely used during later stages of pregnancy to treat infections. Kilbac 750 can pass into breast milk in small amounts, so caution is needed when nursing.
Precautions & Warnings
Kilbac 750 should be used carefully in patients who are taking strong diuretics or have a history of colitis.
Overdose Effects
No information available.
Therapeutic Class
Second-generation Cephalosporins, Vaccines, Anti-sera & Immunoglobulins.
Storage Conditions
Store in a cool, dry place (below 30°C), away from light and moisture. Keep out of reach of children.
Similar Brands of Cefuroxime (Injection – 750mg/vial)
| Brand Name | Form | Strength | Company | MRP (৳) |
|---|---|---|---|---|
| Axet 750mg IV/IM | Injection | 750mg/vial | Orion Pharma Ltd. | 125.85 |
| Axim IV/IM | Injection | 750mg/vial | Aristopharma Limited | 125.0 |
| Cefobac IV/IM | Injection | 750mg/vial | Popular Pharmaceuticals Ltd. | 125.47 |
| Cefotil IV/IM | Injection | 750mg/vial | Square Pharmaceuticals Ltd. | 132.0 |
| Cefuroxime | Injection | 750mg/vial | EDCL | 0.0 |
| Cefu M IV/IM | Injection | 750mg/vial | Medimet Pharmaceuticals Ltd. | 125.0 |
| Cerox A IV/IM | Injection | 750mg/vial | ACI Limited | 126.12 |
| Eurix 750 IV/IM | Injection | 750mg/vial | Ethical Drug Ltd. | 0.0 |
| Famicef IV/IM | Injection | 750mg/vial | The ACME Laboratories Ltd. | 120.82 |
| Fixcef IV/IM | Injection | 750mg/vial | Navana Pharmaceuticals Ltd. | 125.0 |
| Furex IV/IM | Injection | 750mg/vial | Drug International Ltd. | 125.47 |
| Furotil | Injection | 750mg/vial | Healthcare Pharmaceuticals Ltd. | 175.0 |
| Kilmax IV/IM | Injection | 750mg/vial | Eskayef Pharmaceuticals Ltd. | 125.0 |
| Merocef IV/IM | Injection | 750mg/vial | The Ibn Sina Pharmaceutical Ind. Ltd. | 130.0 |
| Mextil IV/IM | Injection | 750mg/vial | Biopharma Ltd. | 125.0 |
| Recofast IV/IM | Injection | 750mg/vial | Rangs Pharmaceuticals Ltd. | 125.37 |
| Roxcef 750 IV/IM | Injection | 750mg/vial | NIPRO JMI Pharma Limited | 125.0 |
| Roxilab 750 | Injection | 750mg/vial | Labaid Pharmaceuticals Ltd. | 175.0 |
| Sefurox IV/IM | Injection | 750mg/vial | Sanofi Bangladesh Ltd. | 125.85 |
| Sefur IV/IM | Injection | 750mg/vial | Opsonin Pharma Limited | 125.85 |
| Turbocef 750 IV/IM | Injection | 750mg/vial | Beximco Pharmaceuticals Ltd. | 125.0 |
| Ximetil IV/IM | Injection | 750mg/vial | Globe Pharmaceuticals Ltd. | 125.0 |